Early Versus Delayed Invasive Strategies in High-Risk Non-ST Elevation Acute Coronary Syndrome Patients - A Systematic Literature Review and Meta-Analysis of Randomised Controlled Trials
- PMID: 28515027
- DOI: 10.1016/j.hlc.2017.02.031
Early Versus Delayed Invasive Strategies in High-Risk Non-ST Elevation Acute Coronary Syndrome Patients - A Systematic Literature Review and Meta-Analysis of Randomised Controlled Trials
Abstract
Rationale: It is unclear whether it is beneficial to perform angiography and/or percutaneous coronary intervention (PCI) as an early or delayed invasive strategy amongst high-risk non-ST elevation acute coronary syndrome (NSTEACS) patients.
Objective: To determine whether an early invasive strategy could further reduce recurrent myocardial infarction (MI) and early mortality compared to a delayed invasive strategy.
Methods and results: We searched MEDLINE, CINAHL and SCOPUS and performed a meta-analysis of nine RCTs with a total of 5274 patients. No statistically significant difference in recurrent MI (RR=0.56, 95% CI 0.17-1.87, p=0.35), early mortality (RR=0.81, 95% CI 0.62-1.05, p=0.11) and major bleeding (RR=0.85, 95% CI 0.66-1.09, p=0.21) was found between groups. A statistically significant reduction in recurrent ischaemia was found amongst patients treated with an early invasive strategy (RR 0.45, 95% CI 0.26-0.78, p=0.004). Subgroup analysis for recurrent MI showed a statistically significant reduction in risk amongst patients treated <24hours compared to≥24hours (RR=0.31, 95% CI 0.11-0.89, p=0.03).
Conclusion: This study suggests that an early invasive strategy may not further reduce recurrent MI and early mortality, but may significantly reduce recurrent ischaemia. However, the recurrent MI endpoint was associated with heterogeneity due to inconsistent MI definitions and strategy timings amongst the included trials. Furthermore, subgroup analysis demonstrated a significant reduction in recurrent MI amongst patients treated <24hours. Therefore, large clinical trials with consistent inclusion criteria are required to confirm whether intervention within 24hours reduces the rate of spontaneous and post-discharge recurrent MI. Future studies with long-term follow-up data are required to detect relevant differences in early mortality. Currently, it appears that stabilised high-risk NSTEACS patients may be safely delayed up to 24hours before undergoing an early invasive strategy.
Keywords: Angiography; Meta-analysis; Non-ST elevation acute coronary syndrome; Percutaneous coronary intervention; Timing.
Copyright © 2017 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.
Similar articles
-
Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.Catheter Cardiovasc Interv. 2020 Feb;95(2):185-193. doi: 10.1002/ccd.28280. Epub 2019 May 21. Catheter Cardiovasc Interv. 2020. PMID: 31111670
-
Timing of invasive strategy in NSTE-ACS patients and effect on clinical outcomes: A systematic review and meta-analysis of randomized controlled trials.Atherosclerosis. 2015 Jul;241(1):48-54. doi: 10.1016/j.atherosclerosis.2015.04.808. Epub 2015 Apr 30. Atherosclerosis. 2015. PMID: 25966439 Review.
-
Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis.JACC Cardiovasc Interv. 2016 Nov 28;9(22):2267-2276. doi: 10.1016/j.jcin.2016.09.017. JACC Cardiovasc Interv. 2016. PMID: 27884352 Review.
-
Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials.Lancet. 2017 Aug 19;390(10096):737-746. doi: 10.1016/S0140-6736(17)31490-3. Epub 2017 Aug 1. Lancet. 2017. PMID: 28778541 Review.
-
Early versus delayed percutaneous coronary intervention for patients with non-ST segment elevation acute coronary syndrome: a meta-analysis of randomized controlled clinical trials.Catheter Cardiovasc Interv. 2013 Feb;81(2):223-31. doi: 10.1002/ccd.24439. Epub 2012 May 24. Catheter Cardiovasc Interv. 2013. PMID: 22488783 Review.
Cited by
-
Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.Heliyon. 2020 Aug 19;6(8):e04661. doi: 10.1016/j.heliyon.2020.e04661. eCollection 2020 Aug. Heliyon. 2020. PMID: 32904265 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous